Tech Company Financing Transactions

Novira Therapeutics Funding Round

5AM Ventures, Canaan Partners and BioAdvance Ventures participated in a $23 million Series A funding round for Novira Therapeutics. The round was announced by the company on 8/23/2012.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

3805 Old Easton Road
Doylestown, PA 18902
USA

Phone

(267) 337-6913

Website

www.noviratherapeutics.com

Email Address

[email protected]

Overview

Novira is an antiviral drug discovery company launched in 2009 that is focused on the discovery of novel, first-in-class therapeutics for the treatment of HBV and HIV, two global diseases in need of better therapies. The company is led by seasoned pharmaceutical industry executives with proven records of success in drug discovery.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Christian Schade

        

Chief Medical Officer

Nathaniel Brown

        

Chief Scientific Officer

Osvaldo Flores

        

Browse more venture capital transactions:

Prev: 8/23/2012: Exosome Diagnostics venture capital transaction
Next: 8/23/2012: PLAiR venture capital transaction

Share this article

Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary